Header
Sir Ganga Ram Hospital, New Delhi

Summary

Chemotherapy cost in India varies widely and depends on the cancer type, the specific drugs used, whether treatment is at a government or private hospital, and how many cycles are needed. Conventional chemotherapy drugs are generally far less expensive than newer targeted therapies or immunotherapy, and oral chemotherapy can sometimes cost a fraction of intravenous regimens.

Government schemes such as Ayushman Bharat and customs duty exemptions on select cancer drugs have reduced costs for many patients, but out-of-pocket spending, including non-medical costs like travel and accommodation, remains a significant burden for Indian families. This page explains the main cost drivers and where to find financial support, but you must confirm exact costs with your treating hospital.

Chemotherapy cost in India: A realistic guide for patients and families

What drives the cost, how many sessions to expect, and where government schemes can help

This page is for informational purposes only and does not replace medical or financial advice. Chemotherapy costs vary by patient, hospital and treatment protocol, so please consult Dr Aditya Sarin or your treating oncologist and hospital billing team for an actual estimate specific to your case. As of 2026, figures reflect the most recent published data available and should be treated as indicative rather than fixed prices.

One of the first questions most families ask after a cancer diagnosis is what treatment will actually cost. Chemotherapy is rarely a single, one-time expense. It usually runs across several months and multiple cycles, and the total bill depends on more variables than most people expect. Here is a realistic look at what shapes chemotherapy cost in India, how many sessions are typically involved, and what support exists for patients who cannot bear the full cost themselves, alongside guidance on choosing where to get treated from Dr Aditya Sarin’s page on choosing the right cancer treatment hospital in India.

What determines the cost of chemotherapy

Chemotherapy cost isn’t fixed because several factors shape the final bill.

The type of cancer and the specific regimen prescribed matter most, since some drug combinations are older and off-patent, while others are newer, patented, or biologic in nature and cost considerably more. Whether treatment involves conventional chemotherapy alone or is combined with targeted therapy or immunotherapy changes the cost substantially, since targeted and immunotherapy drugs are generally the most expensive part of modern cancer treatment.

The type of hospital also matters. Government hospitals and Regional Cancer Centres often provide chemotherapy at little or no direct cost to eligible patients, while private hospitals charge separately for drugs, hospital stays, nursing care, and monitoring. According to a narrative review published in the Journal of Family Medicine and Primary Care in 2023, medicines alone account for 40 to 50 per cent of total out-of-pocket cancer care expenses in India, with diagnostic tests and consultation fees adding further to the bill.

The number of cycles required, whether the patient needs admission or can be treated as a day-care outpatient, and whether complications arise during treatment all add to or reduce the total cost.

How many chemotherapy sessions are usually needed

The number of chemotherapy sessions, referred to as cycles, depends entirely on the type and stage of cancer, the drug regimen, and how the patient responds to treatment. No single number applies across all cancers.

Most standard protocols are given in cycles ranging from four to eight, with each cycle typically spaced two to four weeks apart to allow the body to recover between doses. Some cancers require a shorter course, while others, particularly in the metastatic or advanced setting, may involve ongoing treatment for as long as it controls the disease and side effects stay manageable. This is a decision the treating oncologist makes and regularly reassesses based on scans, blood counts, and how the patient is tolerating treatment, not a fixed schedule set in advance.

Chemotherapy cost per cycle: why there is no single answer

Because chemotherapy cost depends on so many variables, a single average cost per cycle for India as a whole is difficult to state reliably, and figures circulating online often reflect one hospital’s marketing pricing rather than a verified national average.

One frequently cited academic estimate, from a 2013 costing study by Wani et al., found that the average unit cost per patient per bed day for in-patient chemotherapy was approximately Rs 5,725, with patients bearing around 40 per cent of drug costs out of pocket even in that setting. This figure is now more than a decade old and reflects costs at the time of the study, so read it as historical context on cost structure rather than a current price. Newer targeted and immunotherapy-based regimens introduced since then generally cost substantially more per cycle than the conventional chemotherapy drugs covered in that estimate.

The most reliable way to know the actual cost per cycle for a specific diagnosis is a written estimate from the treating hospital, since it will reflect the current drug regimen, hospital charges, and any government scheme the patient qualifies for.

Oral chemotherapy cost

Oral chemotherapy, taken as tablets rather than given through an intravenous infusion, can be considerably less expensive than IV chemotherapy for certain cancers, and it also removes the cost and time associated with day-care hospital visits for each dose.

A notable Indian example comes from a study published in the Indian Journal of Surgical Oncology in 2021, which tested a low-cost, home-based oral metronomic chemotherapy protocol, combining oral methotrexate with celecoxib, in 60 patients with advanced oral cancer. The regimen cost about Rs 700 per month, was fully affordable and well tolerated among enrolled patients, and made 43.3 per cent of them surgically resectable after treatment. This is a specific low-cost protocol for a specific cancer type, not a cost figure that applies to oral chemotherapy in general, since oral targeted therapy drugs used for other cancers can cost far more per month. Whether an oral option exists and is appropriate depends entirely on the cancer type and should be discussed with the treating oncologist.

Government schemes that reduce the cost

Several government measures currently help reduce the financial burden of chemotherapy in India.

Scheme or measure

What it covers

Ayushman Bharat, PM-JAY

Provides chemotherapy, radiotherapy and surgical oncology coverage for eligible economically vulnerable families, with the government reporting that over 90 per cent of registered cancer patients under the scheme had begun treatment as of 2024

Health Minister’s Cancer Patient Fund

Offers financial assistance of up to Rs 5 lakh, extendable to Rs 15 lakh in eligible cases, for patients below the poverty line, distributed through 27 Regional Cancer Centres

2025-26 Union Budget customs duty exemption

Exempted 36 life-saving cancer drugs from basic customs duty and reduced six additional cancer medicines to a concessional 5 per cent duty rate, aimed at lowering drug costs

Day Care Cancer Centres

Government has targeted 200 additional day-care cancer centres in district hospitals for 2025-26, intended to expand access and reduce the need for costly travel to tertiary centres

Source: Press Information Bureau, Government of India, fact sheet on government schemes for cancer care.

Eligibility rules and empanelled hospital lists change periodically, so patients should confirm current coverage directly through the Ayushman Bharat helpline or the treating hospital’s insurance desk.

The real burden: out-of-pocket and non-medical costs

Even where government schemes reduce direct treatment costs, cancer care in India still places a substantial financial burden on many families, and a meaningful part of that burden is not the chemotherapy drug itself.

A study of 474 solid cancer patients at a Regional Cancer Centre in South India, where diagnostics and treatment were free for eligible patients, found the average total out-of-pocket expenditure was still Rs 24,374.8 per patient, and that 96 per cent of this fell in the direct non-medical category, covering travel, accommodation and food during repeated hospital visits, rather than direct medical costs. Out-of-pocket spending was notably higher for male patients, at Rs 35,817, compared with Rs 20,496 for female patients in the same study.

More broadly, the Journal of Family Medicine and Primary Care review cited earlier notes that catastrophic health expenditure, meaning healthcare costs that exceed 40 per cent of a household’s capacity to pay, affected an estimated 61.6 per cent of cervical cancer patients in one Indian study, with around 30 per cent of affected families resorting to distress financing such as borrowing or selling assets. This is why planning for the full cost of treatment, including indirect costs, matters as much as understanding the price of the chemotherapy itself.

The takeaway

Chemotherapy cost in India depends on the cancer type, the drugs used, the hospital, and the number of cycles required, and no single figure applies to every patient. Government schemes and low-cost treatment protocols have improved affordability in specific situations, but non-medical costs during treatment remain a real and often underestimated part of the total burden. For a clear, personalised understanding of your treatment plan and likely cost, book a consultation with Dr Aditya Sarin at Sir Ganga Ram Hospital, New Delhi, or request a second opinion on an existing treatment plan and its cost. 

References

  1. Press Information Bureau, Government of India. Towards a Cancer-Free India. https://www.pib.gov.in/FactsheetDetails.aspx?Id=149131&reg=48&lang=2
  2. Muralidharan S, Gore M, Katkuri S. Cancer care and economic burden, a narrative review. Journal of Family Medicine and Primary Care. 2023;12(12):3042-3047. https://pmc.ncbi.nlm.nih.gov/articles/PMC10866236/
  3. Maurya PK, Murali S, Jayaseelan V, Thulasingam M, Jagadesan P. Economic burden of solid cancer treatment in South India, out-of-pocket expenditure and catastrophic health expenditure. https://pmc.ncbi.nlm.nih.gov/articles/PMC9080359
  4. Study on home-based oral metronomic chemotherapy in advanced oral cancer. Indian Journal of Surgical Oncology. 2021;12:67-72. https://link.springer.com/doi/10.1007/s13193-020-01247-8

Frequently Asked Questions

What is the average cost of one chemotherapy cycle in India?

There is no single reliable average, since cost depends heavily on the cancer type, the drugs used, and the hospital. The only accurate way to know the cost for a specific case is a written estimate from the treating hospital, based on the prescribed regimen.

Is chemotherapy free under Ayushman Bharat?

Ayushman Bharat PM-JAY covers chemotherapy, radiotherapy and surgical oncology for eligible economically vulnerable families at empanelled hospitals, though coverage should be confirmed directly, since scheme rules and hospital lists change periodically.

Is oral chemotherapy always cheaper than IV chemotherapy?

Not always. Some low-cost oral regimens exist for specific cancers, but newer oral targeted therapy drugs used for other cancers can cost as much as, or more than, intravenous chemotherapy. Whether an oral option exists depends entirely on the cancer involved.

Beyond drug costs, what other expenses should families plan for?

Studies from Indian cancer centres consistently show non-medical costs, including travel, accommodation and time away from work for repeated hospital visits, can make up the majority of a family’s total out-of-pocket spending, even when the treatment itself is subsidised or free.

Dr. Aditya Sarin — Medical Oncologist, Sir Ganga Ram Hospital, Delhi
Medically reviewed & written by

Dr. Aditya Sarin

Consultant, Medical Oncology · Sir Ganga Ram Hospital, New Delhi

MD (General Medicine) · DrNB (Medical Oncology) · ESMO (European) Board Certified

Dr. Aditya Sarin is a medical oncologist who combines precision molecular profiling with evidence-based, compassionate cancer care. Named Young Medical Oncologist of the Year, he treats the full spectrum of solid and blood cancers through a multidisciplinary tumor-board approach at Sir Ganga Ram Hospital.

Breast Cancer Lung Cancer GI Cancers Head & Neck Gynecologic Cancers Immunotherapy Targeted Therapy Precision / Molecular Oncology Leukemia · Lymphoma · Myeloma

Leave a Reply

Your email address will not be published. Required fields are marked *

This field is required.

This field is required.